Navigation Links
Hospira to Host Conference Call for Second-Quarter 2011 Results
Date:6/27/2011

LAKE FOREST, Ill., June 27, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its second-quarter 2011 results on Wednesday, July 27, 2011 at 8 a.m. Central time.  

The company will release its second-quarter results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call and related material will be available on Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the Hospira website for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
2. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
3. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
4. Hospira Reports First-Quarter 2011 Results
5. Hospira Board Authorizes $1 Billion Share Repurchase Program
6. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
7. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
8. Hospira to Host Conference Call for First-Quarter 2011 Results
9. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
10. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
11. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017 Secretary of Health ... Programs Secretary Gary Tennis are warning Pennsylvanians ... two recent overdose deaths from the drug in ... is intended to sedate large animals and is not ... who comes into contact with it," Secretary Murphy said. ...
(Date:1/17/2017)... , Jan. 17, 2017 The interventional radiology ... by 2021 from USD 6.35 billion in 2016, at ... the growth of this market are rising incidence of ... minimally invasive surgeries. The global interventional radiology ... and region. On the basis of type, the stents ...
(Date:1/17/2017)... 17, 2017  Pennsylvania Secretary of Health Dr. ... medical marijuana growers/processors and dispensaries are now available ... . Permit applications will be accepted from February ... is an important step forward in getting this ... Secretary Murphy said. "We,ve developed a thorough application ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... well as Palm Desert, is opening a new office in San Clemente, California ... magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with major depression. ...
(Date:1/17/2017)... , ... January 17, 2017 , ... A prescription medication ... of the fourth Cradle to Cradle Product Design Challenge , the Cradle ... a series of six circular design challenges scheduled to run through early 2018. The ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare company ... clinical study for its dental gel that shows significant reduction in plaque levels and ... triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine and ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Many people make New Year’s resolutions or renew ... Mondavi is making it easier for people who want to kick off 2017 with ... and existing patients. , These special offers include: , , ...
Breaking Medicine News(10 mins):